Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus‐1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub‐study A5334s

AIMS: AIDS Clinical Trials Group study A5334s evaluated the pharmacokinetics of raltegravir before and during combined administration of ombitasvir, paritaprevir/ritonavir, plus dasabuvir (OBV/PTV/r + DSV) and weight‐based ribavirin in human immunodeficiency virus (HIV) and hepatitis C virus (HCV) c...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Br J Clin Pharmacol
Huvudupphovsmän: Venuto, Charles S., Cramer, Yoninah S., Rosenkranz, Susan L., Sulkowski, Mark, Wyles, David L., Cohen, Daniel E., Schmidt, Jeffrey, Alston‐Smith, Beverly L., Morse, Gene D.
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2019
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6983509/
https://ncbi.nlm.nih.gov/pubmed/31656054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14148
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk